MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients.
Martín-Flores, Núria
MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients. [electronic resource] - Molecular neurobiology Mar 2019 - 2092-2100 p. digital
Publication Type: Journal Article
1559-1182
10.1007/s12035-018-1219-1 doi
Alleles
Dyskinesia, Drug-Induced--genetics
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Levodopa--adverse effects
Parkinson Disease--drug therapy
Polymorphism, Single Nucleotide
Retrospective Studies
Signal Transduction--genetics
TOR Serine-Threonine Kinases--genetics
MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients. [electronic resource] - Molecular neurobiology Mar 2019 - 2092-2100 p. digital
Publication Type: Journal Article
1559-1182
10.1007/s12035-018-1219-1 doi
Alleles
Dyskinesia, Drug-Induced--genetics
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Levodopa--adverse effects
Parkinson Disease--drug therapy
Polymorphism, Single Nucleotide
Retrospective Studies
Signal Transduction--genetics
TOR Serine-Threonine Kinases--genetics